BioNTech vaccine agent, Fosun Pharma, seeks more global sales through M&A opportunities, push into new markets

//BioNTech vaccine agent, Fosun Pharma, seeks more global sales through M&A opportunities, push into new markets

BioNTech vaccine agent, Fosun Pharma, seeks more global sales through M&A opportunities, push into new markets

Shanghai Fosun Pharmaceutical (Group), controlled by conglomerate Fosun International, hopes to expand its international footprint through mergers and acquisitions (M&As) and sales of its innovative drugs in more overseas markets.The Hong Kong and Shanghai-listed group, which holds the distribution rights for BioNTech’s Covid-19 vaccine in Hong Kong and Macau, aims to increase its offshore sales to 40 per cent of group revenue over the next five years, chairman and chief executive officer Wu…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2021-04-01T05:05:13+00:00 April 1st, 2021|Business|Comments Off on BioNTech vaccine agent, Fosun Pharma, seeks more global sales through M&A opportunities, push into new markets